Calidi Biotherapeutics
Yahoo Finance • 10 days ago
RXO Stock Has Surged 75% Since This Fund Made a $10 Million Bet
On May 14, 2026, Finepoint Capital LP disclosed a first-quarter buy of 684,829 RXO(NYSE:RXO) shares, an estimated $10.05 million trade based on quarterly average pricing. What happened According to a SEC filing dated May 14, 2026, Finepo... Full story
Yahoo Finance • 2 months ago
Calidi Releases New Data On RedTail Mechanism For Cancer Treatment
(RTTNews) - Calidi Biotherapeutics Inc. (CLDI), a clinical-stage biotechnology company, released on Monday new data on the approach of simultaneous T-cell activation and expression of T-cell engagers in the tumor microenvironment at the 20... Full story
Yahoo Finance • 2 months ago
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trialThe Company has received feedback from the FDA through Type D interactions, and the Company believes its manufacturing and analytical approaches fo... Full story
Yahoo Finance • 3 months ago
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced the closing o... Full story
Yahoo Finance • 3 months ago
Calidi Biotherapeutics Announces Proposed Public Offering
SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it inten... Full story